Global Burden of Disease (GBD)
Seattle, US · 1 known investors
IHME is an independent research institute at the University of Washington School of Medicine that generates scientific evidence on global health outcomes, disease burden, and forecasting to inform policy and health system decisions. The organization develops health metrics, applies AI and statistical methods to health data analysis, and studies health system capacity, climate impacts on health, and health equity across populations worldwide.
Founders & leadership
CJ
Christopher J.L. MurrayinProfessor; IHME Director; Chair, Department of Health Metrics Sciences
Investors · 1
Frequently asked questions
- What does Global Burden of Disease (GBD) do?
- IHME is an independent research institute at the University of Washington School of Medicine that generates scientific evidence on global health outcomes, disease burden, and forecasting to inform policy and health system decisions. The organization develops health metrics, applies AI and statistical methods to health data analysis, and studies health system capacity, climate impacts on health, and health equity across populations worldwide.
- Who are Global Burden of Disease (GBD)'s investors?
- Global Burden of Disease (GBD)'s investors include LeapFrog Investments.
- Where is Global Burden of Disease (GBD) headquartered?
- Global Burden of Disease (GBD) is headquartered in Seattle, US.